Go Pro
→ The dollar reset no one told you about (From Porter & Company) (Ad)tc pixel Free NNOX Stock Alerts

Nano-X Imaging (NNOX) Competitors

Nano-X Imaging logo
$1.05 0.00 (0.00%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$1.03 -0.02 (-1.62%)
As of 06:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

NNOX vs. CARL, SGHT, CNXU, TLSI, and TMCI

Should you buy Nano-X Imaging stock or one of its competitors? MarketBeat compares Nano-X Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nano-X Imaging include Carlsmed (CARL), Sight Sciences (SGHT), Conexeu Sciences (CNXU), TriSalus Life Sciences (TLSI), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.

How does Nano-X Imaging compare to Carlsmed?

Nano-X Imaging (NASDAQ:NNOX) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

21.5% of Nano-X Imaging shares are held by institutional investors. 12.9% of Carlsmed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Carlsmed has a net margin of -57.76% compared to Nano-X Imaging's net margin of -716.44%. Carlsmed's return on equity of -60.74% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-716.44% -70.96% -62.26%
Carlsmed -57.76%-60.74%-29.84%

Carlsmed has higher revenue and earnings than Nano-X Imaging. Carlsmed is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$13.02M5.61-$75.02M-$1.58N/A
Carlsmed$50.51M6.52-$29.63M-$2.51N/A

In the previous week, Nano-X Imaging had 26 more articles in the media than Carlsmed. MarketBeat recorded 28 mentions for Nano-X Imaging and 2 mentions for Carlsmed. Carlsmed's average media sentiment score of 0.94 beat Nano-X Imaging's score of 0.06 indicating that Carlsmed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nano-X Imaging
2 Very Positive mention(s)
0 Positive mention(s)
24 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Carlsmed
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Nano-X Imaging currently has a consensus price target of $4.00, indicating a potential upside of 280.95%. Carlsmed has a consensus price target of $18.75, indicating a potential upside of 54.83%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities analysts plainly believe Nano-X Imaging is more favorable than Carlsmed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67
Carlsmed
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Carlsmed beats Nano-X Imaging on 9 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Sight Sciences has higher revenue and earnings than Nano-X Imaging. Sight Sciences is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$77.36M3.76-$38.43M-$0.71N/A
Nano-X Imaging$13.02M5.61-$75.02M-$1.58N/A

Sight Sciences presently has a consensus price target of $8.25, suggesting a potential upside of 54.49%. Nano-X Imaging has a consensus price target of $4.00, suggesting a potential upside of 280.95%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.44
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67

In the previous week, Nano-X Imaging had 15 more articles in the media than Sight Sciences. MarketBeat recorded 28 mentions for Nano-X Imaging and 13 mentions for Sight Sciences. Nano-X Imaging's average media sentiment score of 0.06 beat Sight Sciences' score of -0.15 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sight Sciences
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nano-X Imaging
2 Very Positive mention(s)
0 Positive mention(s)
24 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sight Sciences has a net margin of -46.83% compared to Nano-X Imaging's net margin of -716.44%. Sight Sciences' return on equity of -52.34% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-46.83% -52.34% -28.49%
Nano-X Imaging -716.44%-70.96%-62.26%

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 30.4% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Sight Sciences has a beta of 2.38, suggesting that its share price is 138% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

Summary

Sight Sciences beats Nano-X Imaging on 10 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, Nano-X Imaging had 24 more articles in the media than Conexeu Sciences. MarketBeat recorded 28 mentions for Nano-X Imaging and 4 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.29 beat Nano-X Imaging's score of 0.06 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Conexeu Sciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nano-X Imaging
2 Very Positive mention(s)
0 Positive mention(s)
24 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Conexeu Sciences has a net margin of 0.00% compared to Nano-X Imaging's net margin of -716.44%. Conexeu Sciences' return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Conexeu SciencesN/A N/A N/A
Nano-X Imaging -716.44%-70.96%-62.26%

Conexeu Sciences presently has a consensus price target of $20.00, indicating a potential upside of 93.42%. Nano-X Imaging has a consensus price target of $4.00, indicating a potential upside of 280.95%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Conexeu Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Conexeu Sciences
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67

21.5% of Nano-X Imaging shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Conexeu Sciences has higher earnings, but lower revenue than Nano-X Imaging. Conexeu Sciences is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conexeu SciencesN/AN/AN/A-$0.11N/A
Nano-X Imaging$13.02M5.61-$75.02M-$1.58N/A

Summary

Nano-X Imaging beats Conexeu Sciences on 7 of the 12 factors compared between the two stocks.

How does Nano-X Imaging compare to TriSalus Life Sciences?

Nano-X Imaging (NASDAQ:NNOX) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

TriSalus Life Sciences has higher revenue and earnings than Nano-X Imaging. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$13.02M5.61-$75.02M-$1.58N/A
TriSalus Life Sciences$45.15M5.75-$39.23M-$1.41N/A

Nano-X Imaging has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

In the previous week, Nano-X Imaging had 27 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 28 mentions for Nano-X Imaging and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.89 beat Nano-X Imaging's score of 0.06 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Nano-X Imaging Neutral
TriSalus Life Sciences Very Positive

Nano-X Imaging presently has a consensus price target of $4.00, indicating a potential upside of 280.95%. TriSalus Life Sciences has a consensus price target of $7.50, indicating a potential upside of 77.30%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, equities research analysts clearly believe Nano-X Imaging is more favorable than TriSalus Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

TriSalus Life Sciences has a net margin of -60.85% compared to Nano-X Imaging's net margin of -716.44%. TriSalus Life Sciences' return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-716.44% -70.96% -62.26%
TriSalus Life Sciences -60.85%N/A -69.91%

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

TriSalus Life Sciences beats Nano-X Imaging on 9 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

Treace Medical Concepts has a net margin of -29.44% compared to Nano-X Imaging's net margin of -716.44%. Treace Medical Concepts' return on equity of -67.04% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-29.44% -67.04% -30.28%
Nano-X Imaging -716.44%-70.96%-62.26%

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Treace Medical Concepts presently has a consensus target price of $4.77, indicating a potential upside of 4.15%. Nano-X Imaging has a consensus target price of $4.00, indicating a potential upside of 280.95%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Treace Medical Concepts.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
2 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.86
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67

Treace Medical Concepts has higher revenue and earnings than Nano-X Imaging. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$212.69M1.40-$59M-$0.97N/A
Nano-X Imaging$13.02M5.61-$75.02M-$1.58N/A

In the previous week, Nano-X Imaging had 25 more articles in the media than Treace Medical Concepts. MarketBeat recorded 28 mentions for Nano-X Imaging and 3 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.14 beat Nano-X Imaging's score of 0.06 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Treace Medical Concepts
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nano-X Imaging
2 Very Positive mention(s)
0 Positive mention(s)
24 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Treace Medical Concepts has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market.

Summary

Treace Medical Concepts beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NNOX vs. The Competition

Export
MetricNano-X ImagingTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$73.07M$4.07B$6.90B$12.61B
Dividend YieldN/A2.20%3.12%8.00%
P/E Ratio-0.6634.9728.6424.26
Price / Sales5.6143.92344.87117.88
Price / CashN/A36.8823.2149.36
Price / Book0.524.145.706.29
Net Income-$75.02M$31.58M$203.89M$330.66M
7 Day Performance-15.32%-2.09%-1.59%-1.35%
1 Month Performance-40.34%-6.81%-2.23%-0.64%
1 Year Performance-79.61%1.19%13.25%19.08%

Nano-X Imaging Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NNOX
Nano-X Imaging
3.7231 of 5 stars		$1.05
flat		$4.00
+281.0%		-79.2%$73.07M$13.02MN/A190
CARL
Carlsmed
2.4769 of 5 stars		$12.29
+8.4%		$18.75
+52.6%		N/A$308.28M$50.51MN/A100
SGHT
Sight Sciences
3.5172 of 5 stars		$5.48
+0.6%		$8.14
+48.6%		+56.6%$296.53M$77.36MN/A210
CNXU
Conexeu Sciences
2.8337 of 5 stars		$10.80
-0.6%		$20.00
+85.2%		N/A$288.99MN/AN/A4
TLSI
TriSalus Life Sciences
3.022 of 5 stars		$4.31
-8.1%		$7.50
+74.0%		-13.5%$288.04M$45.15MN/A106

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel
Forget SpaceX, this is Elon’s Next Breakthrough
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel